Description (Description)
Gabapentin Capsule
Product Images NDC 80425-0199
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0199). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 1 (Fig 1)
This appears to be a chart or graph displaying the mean pain score during a clinical trial. The trial appears to have involved a four-week dose titration period followed by a four-week fixed dose period. Two treatments were compared: placebo and gabapentin at a dose of 3,600 mg/day. The chart shows pain scores at baseline and at various time points during the trial. No further information is available.*
Label 1 (Lable 1)
This is a description of Gabapentin 100mg Capsule with a quantity of 60 capsules. The medication is labeled "Neurontin" with an expiration date of 10/31/2023. There is also a word "LIV e" which cannot be evaluated as it appears to be a misread text.*
Label 2 (Lable 2)
Fig 2 (Fig 2)
This is a graph displaying the mean pain score of a study with a 3-week dose titration period and a 4-week fixed dose period using a placebo and two doses of gabapentin (1,800 mg/day and 2,400 mg/day). The data is shown over six time points (baseline and weeks 1-5) labeled on the x-axis and the mean pain score is shown on the y-axis.*
Fig 3 (Fig 3)
Fig 4 (Fig 4)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
